Callan JMB Inc. (NASDAQ: CJMB), an integrative logistics company serving the healthcare industry and emergency management agencies, reported its financial results for the third quarter ended September 30, 2025, and provided a business update. The company expanded its compliance-driven logistics platform into the food sampling industry and entered a preliminary agreement to install oral drug delivery system manufacturing equipment at its Texas cGMP facility, as part of ongoing initiatives with global healthcare manufacturing leaders. Callan JMB established a subsidiary in India, Callan JMB Services (India) Private Limited, and advanced plans for a temperature-controlled pharmaceutical warehouse in Pune, Maharashtra. The company secured an agreement with Walker's Pharmaceuticals Ltd. and is working with other Indian companies to facilitate U.S. market entry and manufacturing plant establishment. The company extended its emergency preparedness contract with the City of Chicago through June 2026, increasing total funding by $1.5 million to $9.1 million, and continued its seven-year partnership for health preparedness supply management and distribution. In October, Callan JMB upgraded its proprietary Sentry Monitoring System to version 4.0, moving from Java to HTML5, enabling monitoring of temperature-sensitive pharmaceutical storage via any web-enabled device.